Studies from Kane Biotech Inc. Describe New Findings in Microorganism Research (Wound Gel Formulations Containing Poloxamer 407 and Polyhexanide Have In Vitro Antimicrobial and Antibiofilm Activity Against Wound-Associated Microbial...).

A recent study by Kane Biotech Inc. in Winnipeg, Canada, focused on the antimicrobial and antibiofilm activity of wound gel formulations containing Poloxamer 407 and Polyhexanide against common wound-associated microbial pathogens. The research found that wound gels with higher pH levels exhibited stronger antimicrobial activity, while concentrations of Poloxamer 407 above 20% had a negative impact. The study concluded that these wound gel formulations could potentially offer a new treatment option for chronic wounds, as they showed antimicrobial, antibiofilm, and biofilm inhibition activity against all tested species in vitro. [Extracted from the article]